Xilio Therapeutics Inc.

0.72
0.04 (5.73%)
At close: Apr 02, 2025, 3:59 PM
0.72
0.12%
After-hours: Apr 02, 2025, 07:02 PM EDT

Xilio Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue 6.34M n/a n/a n/a n/a n/a
Cost of Revenue n/a 1.9M 1.85M 1.5M 1.06M 240K
Gross Profit 6.34M -1.9M -1.85M -1.5M -1.06M -240K
Operating Income -60.58M -79.13M -89.15M -75.04M -54.56M -19.03M
Interest Income n/a n/a n/a 600.00 600.00 n/a
Pretax Income -58.24M -76.4M -88.22M -75.8M -55.22M -17.31M
Net Income -58.24M -76.4M -87.3M -74.3M -55.22M -17.31M
Selling & General & Admin 24.78M 27M 29.95M 23.86M 10.65M 4.77M
Research & Development 41.21M 52.14M 59.2M 51.19M 43.91M 14.26M
Other Expenses 937K n/a 927K -756K -656K 1.72M
Operating Expenses 66.93M 79.13M 89.15M 75.04M 54.56M 19.03M
Interest Expense n/a n/a n/a 600K 600K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 66.93M 79.13M 89.15M 75.04M 54.56M 19.03M
Income Tax n/a n/a -927K -1.5M 858.7K 68.14K
Shares Outstanding (Basic) 53.51M 27.5M 27.39M 27.36M 27.47M 27.47B
Shares Outstanding (Diluted) 53.51M 27.5M 27.39M 27.36M 27.47M 27.47B
EPS (Basic) -1.09 -2.78 -3.19 -2.72 -2.01 -0.00
EPS (Diluted) -1.09 -2.78 -3.19 -2.72 -2.01 -0.00
EBITDA -58M -73.8M -85.58M -73.7M -53.5M -17.07M
EBIT -59.65M -75.7M -87.42M -75.2M -54.62M -17.31M
Depreciation & Amortization 1.64M 1.9M 1.85M 1.5M 1.06M 240K